Joshua Bomsztyk
4PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jun 06, 2024
Response rates to second-line treatment with daratumumab bortezomib dexamethasone (DVD) in relapsed/refractory light chain amyloidosis (AL) after initial Bortezomib-based regime.Joshua Bomsztyk, Sriram Ravichandran, Jahanzaib Khwaja
|Jan 09, 2024
Complete responses in AL amyloidosis are unequal: the impact of free light chain mass spectrometry in AL amyloidosis.Joshua Bomsztyk, Sriram Ravichandran, Hannah V Giles
|Jan 03, 2024
Real-world efficacy of single-agent belantamab mafodotin in relapsed systemic AL amyloidosis.Jahanzaib Khwaja, Joshua Bomsztyk, Maria Atta
|Aug 30, 2022
Recent guidelines for high-dose chemotherapy and autologous stem cell transplant for systemic AL amyloidosis: a practitioner's perspective.Joshua Bomsztyk, Jahanzaib Khwaja, Ashutosh D Wechalekar
Pageof 1
Frequent Collaborators
3 joint publications
Jahanzaib Khwaja
2 joint publications
Sriram Ravichandran
1 joint publications
Ceri Bygrave
1 joint publications
Oonagh Sheehy
1 joint publications
Oscar Berlanga
1 joint publications
Muhammad U Rauf
1 joint publications
Ana Martinez-Naharro
1 joint publications
Lucia Venneri
1 joint publications
Guy Pratt
